MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/arclin/acab087

Медицинская библиотека · Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists · 2022

Impact of Psychiatric Illnesses and Selective Serotonin Reuptake Inhibitor Medications on Baseline Neurocognitive Testing.

Asfaw Zerubabbel K, Hannah Theodore C, Ali Muhammad, Li Adam Y, Spiera Zachary, Marayati Naoum Fares, Kalagara Roshini, Dreher Nickolas, Schupper Alexander J, Gometz Alex, Lovell Mark R, Choudhri Tanvir

СтатьяПеревод в очереди

Аннотация

INTRODUCTION

Neurocognitive tests are an integral component of sport-related concussion (SRC) workup. A history of psychiatric illness (HPI) is common among young athletes. Investigations of factors that influence athletes' baseline neurocognitive function are crucial for an accurate assessment of SRC.

OBJECTIVE

In this study, we aim to elucidate the effect of HPI and selective-serotonin reuptake inhibitor (SSRI) medication use on baseline neurocognitive performance in young athletes.

METHODS

We conducted a retrospective cross-sectional study of Immediate Post-Concussion Assessment and Cognitive Testing assessments. A total of 268 athletes with HPI and a control group of 6,364 athletes were included. The outcomes were total symptom score based on post-concussion symptom scale, verbal memory, visual memory, visual motor, reaction time, and impulse control scores with self-reported HPI status and SSRI use.

RESULTS

Athletes with HPI had an elevated symptom score in both univariate analysis (p < .0001) and multivariate analysis (p < .0001). HPI influence on visual memory score was not robust to multivariate analysis (p = .24). Athletes with HPI who reported SSRI medication use had the same baseline neurocognitive performance as other athletes with HPI. HPI influences athletes' baseline neurocognitive performance by elevating symptom scores. HPI does not alter any of the objective neurocognitive composite scores in contrast to previous work.

CONCLUSIONS

Clinicians should consider the impact of HPI on baseline neurocognitive performance during the assessment of a suspected SRC. Additional research is required to bolster our findings on SSRI use and ascertain the effects of other drug classes on baseline neurocognitive performance.

Для цитирования: Asfaw Zerubabbel K, Hannah Theodore C, Ali Muhammad, Li Adam Y, Spiera Zachary, Marayati Naoum Fares, Kalagara Roshini, Dreher Nickolas, Schupper Alexander J, Gometz Alex, Lovell Mark R, Choudhri Tanvir. Impact of Psychiatric Illnesses and Selective Serotonin Reuptake Inhibitor Medications on Baseline Neurocognitive Testing.. Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists. 2022. DOI: 10.1093/arclin/acab087.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.